Labcorp Holdings Inc. closed 9.72% below its 52-week high of $258.59, which the company reached on March 5th.
Other pharmaceutical and health care companies recently announced layoffs — including Bayer, Siemens, RWJBarnabas Health and ...
Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide ...
In the latest quarter, 8 analysts provided ratings for Labcorp Hldgs LH, showcasing a mix of bullish and bearish perspectives ...
AI fundraises, tech partnerships and M&A deals, including DispatchHealth and Medically Home's tie-up, and plans for a ...
5d
Fintel on MSNRedburn Atlantic Initiates Coverage of Labcorp Holdings (LH) with Buy RecommendationFintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Labcorp Holdings (NYSE:LH) with a Buy ...
A New Jersey laboratory which had parts of its business acquired by Labcorp earlier this month has laid off 81 employees.
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer ...
Redburn Atlantic initiated coverage of Labcorp (LH) with a Buy rating and $276 price target Don't Miss Our End of Quarter Offers: Discover the ...
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Labcorp's pTau-217/Beta Amyloid 42 Ratio blood test meets the performance criteria to confirm amyloid pathology consistent with Alzheimer's disease BURLINGTON, N.C., April 2, 2025 /PRNewswire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results